Get started
Author

Win Sen Heng

Observed name: Heng, Win Sen
Institution: UCSI University
ORCID: 0000-0002-4513-8770
Observed ORCID: 0000-0002-4513-8770
OpenAlex ID: A5030854445
Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting
2018 · Win Sen Heng, Reinoud Gosens, et al. · Biochemical Pharmacology · 137
PDF
Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma
2020 · Win Sen Heng, Shiau-Chuen Cheah · Molecules · 51
PDF
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
2023 · Pui Yan Siak, Win Sen Heng, et al. · Journal of Translational Medicine · 50
PDF
Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells
2021 · Win Sen Heng, Frank A. E. Kruyt, et al. · International Journal of Molecular Sciences · 28
PDF
A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker
2021 · Win Sen Heng, Milind Pore, et al. · Lung Cancer · 13
PDF
Identification of Phytochemical-Based β-Catenin Nuclear Localization Inhibitor in NSCLC: Differential Targeting Population from Member of Isothiocyanates
2021 · Win Sen Heng, Shiau-Chuen Cheah · Molecules · 13
PDF
TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells
2022 · Margot de Looff, Win Sen Heng, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Lung Cancer Stem Cells
2022 · Win Sen Heng
PDF
Chalcones and isothiocyanates inhibit nuclear localization of beta catenin in non-small cell lung carcinoma.rar
2019 · Shiau Chuen Cheah, Heng, Win Sen · Figshare
Works count: 9
Citation count: 293
H-index: 6
I10-index: 6
Year
Topic
Type